Ex Parte Moffitt et alDownload PDFPatent Trials and Appeals BoardApr 12, 201613470328 - (D) (P.T.A.B. Apr. 12, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 13/470,328 05/13/2012 50638 7590 04/13/2016 Boston Scientific Neuromodulation Corp. c/o Lowe Graham Jones 701 Fifth Avenue Suite 4800 Seattle, WA 98104 FIRST NAMED INVENTOR Michael A. Moffitt UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. BSNC-1-453.3 5934 EXAMINER CAREY, MICHAEL JAMES ART UNIT PAPER NUMBER 3766 MAILDATE DELIVERY MODE 04/13/2016 PAPER Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte MICHAEL A. MOFFITT, SRIDHAR KOTHANDARAMAN, and DAVID K. L. PETERSON Appeal2014-003729 Application 13/470,328 1 Technology Center 3700 Before BIBHU R. MOHANTY, KENNETH G. SCHOPPER, and AMEE A. SHAH, Administrative Patent Judges. SCHOPPER, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134 from the rejection of claims 39--41and43-52. We have jurisdiction under 35 U.S.C. § 6(b). We affirm- in-part. BACKGROUND According to Appellants, "[t]he present invention relates to management of stimulation safety limits, and more particularly, to 1 According to Appellants, the real party in interest is Boston Scientific Neuromodulation Corporation. Appeal Br. 2. Appeal2014-003729 Application 13/470,328 management of tissue charge safety limits in a neurostimulation system." Spec. ,-r 2. CLAIMS Claims 39--41 and 43-52 are on appeal. 2 Claims 39 and 44 are illustrative of the appealed claims and recite: 39. A neurostimulation system for concurrent use with a plurality of electrodes, comprising: a neurostimulator configured for delivering electrical stimulation energy to a tissue region, thereby injecting a charge into the tissue region at each of the electrodes; memory storing a hard stop charge limit; and an external control device configured for displacing the electrical stimulation energy along the tissue region in one direction, while preventing a value of the charge injection at each of the electrodes from meeting or exceeding the hard stop charge limit. 44. A neurostimulation system for use with at least one electrode, compnsmg: a neurostimulator configured for delivering electrical stimulation energy to a tissue region in accordance with a stimulation parameter, thereby injecting a charge into the tissue region at the at least one electrode; an external control device configured for allowing a user to modify the stimulation parameter; memory storing a hard stop charge limit; and control circuitry configured for modifying the hard stop charge limit based on a characteristic of the at least one electrode, determining a tissue charge injection metric at the at least one electrode, comparing the tissue charge injection metric to the 2 Claims 42 and 53-55 have been identified as having allowable subject matter and are not on appeal. See Final Action 6; Appeal Br. 2. 2 Appeal2014-003729 Application 13/470,328 modified hard stop charge nmn, and preventing the neurostimulator from delivering the electrical stimulation energy to the tissue region in accordance with the modified stimulation parameter based on the comparison. Appeal Br. 8-9. REJECTIONS 1. The Examiner rejects claims 39--41and43 under 35 U.S.C. § 103(a) as unpatentable over Libbus3 in view of Armstrong4 and Greenberg. 5 2. The Examiner rejects claims 44--52 under 35 U.S.C. § 103(a) as unpatentable over Lib bus in view of Greenberg, Swartz, 6 and Goetz. 7 DISCUSSION Libbus in view of Armstrong and Greenberg Claim 39 requires, inter alia, "an external control device configured for displacing the electrical stimulation energy along the tissue region in one direction .... " We are persuaded by Appellants' argument that the proposed combination of art does not teach or suggest this limitation. See Appeal Br. 5---6. During prosecution, claims are given "their broadest reasonable interpretation consistent with the specification" and "in light of the specification as it would be interpreted by one of ordinary skill in the art." 3 Libbus et al., US 2009/0228079 Al, pub. Sept. 10, 2009. 4 Armstrong, US 2008/0269839 Al, pub. Oct. 30, 2008. 5 Greenberg et al., US 2007/0255319 Al, pub. Nov. 1, 2007. 6 Swartz et al., US 5,470,347, iss. Nov. 28, 1995. 7 Goetz et al., US 2009/0198306 Al, pub. Aug. 6, 2009. 3 Appeal2014-003729 Application 13/470,328 In re Am. Acad. of Sci. Tech. Ctr., 367 F.3d 1359, 1364 (Fed. Cir. 2004). Here, we agree with Appellants that the broadest reasonable interpretation of claim 39 requires that "displacing the electrical stimulation energy along the tissue region in one direction" refers to the electrical energy provided by the neurostimulator. This interpretation is consistent with the remainder of the claim, which requires a neurostimulator configured for delivering electrical stimulation and a control device configured for displacing that electrical stimulation, and the Specification. See Spec. i-f 115. Thus, we find that the Examiner's interpretation of the claim as requiring only the propagation of energy in one direction, including a propagating action potential, is unreasonably broad. With respect to the cited art, the Examiner relies only on a portion of Armstrong that discloses delivering a stimulation signal that initiates a uni-directional action potential. See Final Action 2-3; Ans. 3; Armstrong i-f 27. Based on the broadest reasonable interpretation of the claim provided above, we agree with Appellants that Armstrong does not disclose displacing electrical stimulation energy in one direction as claimed. Thus, we determine that the Examiner failed to establish a prima facie showing of obviousness with respect to claim 39. Accordingly, we do not sustain the rejection of claim 39 and dependent claims 40, 41, and 43. Lib bus in view of Greenberg, Swartz, and Goetz Appellants argue claims 44--52 as a group. Appeal Br. 6. We select claim 44 as representative. Claims 45-52 stand or fall with claim 44. See 37 C.F.R. § 41.37(c)(l)(iv (2014). With respect to claim 44, the Examiner finds that Libbus teaches a device as claimed. See Final Action 3--4 (citing Libbus i-fi-17, 30, 33, 36, 37, 47; Figs. 1, 3, 6, 7); see also Ans. 3--4. Although the rejection lists 4 Appeal2014-003729 Application 13/470,328 Greenberg, Swartz, and Goetz, the Examiner acknowledges that the rejection of claim 44 relies only on the disclosure of Lib bus. See Ans. 4. We agree with and adopt the Examiner's findings and conclusions regarding claim 44. See Final Action 3---6; Ans. 3--4. As discussed below, we are not persuaded by Appellants' arguments. Appellants argue only that the Examiner has not shown that Libbus discloses circuitry configured for modifying the hard stop charge limit. Appeal Br. 6-7; Reply Br. 3. In support, Appellants assert that Libbus i-f 33 only discloses modifying a stimulation parameter. Libbus i-f 33 discloses providing hard stop limit detection in the form of a safety-control event detection module, but does not disclose modifying a hard stop charge limit. However, the Examiner cites other paragraphs in Libbus that teach modifying a hard stop charge limit. See, e.g., Ans 4 (citing Libbus i-fi-136, 37). Specifically, Libbus includes a safety-control event detection module that detects when stimulation energy exceeds a predetermined threshold in order to prevent "excessive delivery of energy due to excessive stimulation amplitude and/or frequency." Libbus i-f 36. Libbus further discloses that the safety-control event detection module may including "a threshold adjustment module that dynamically adjusts the threshold value based on at least the value of another stimulation parameter." Id. at i-f 37. Thus, we find reasonable the Examiner's finding that Libbus discloses control circuity configured for modifying the hard stop charge limit based on a characteristic as required by claim 44. Finally, to the extent Appellants discuss whether Libbus discloses the failure of an electrode, it is not clear how said discussion has any bearing on the rejection before us. See App. Br. 6. 5 Appeal2014-003729 Application 13/470,328 Based on the foregoing, we find that the Examiner established a prima facie showing of obviousness without error. Accordingly, we sustain the rejection of claim 44. We also sustain the rejections of claims 45-52 as they fall with claim 44. CONCLUSION For the reasons set forth above, we reverse the rejection of claims 39- 41 and 43; and we affirm the rejections of claims 44--52. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a)(l )(iv). AFFIRMED-IN-PART 6 Copy with citationCopy as parenthetical citation